AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug safety issues; Monitor drug pricing legislation; Continue monitoring of Affordable Prescriptions for Patients Act of 2019 from 116th Congress; Continue monitoring of Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 from 116th Congress; Continue monitoring of Elijah E. Cummings Lower Drug Costs Now Act from 116th Congress; Continue monitoring of Prescription Drug Pricing Reduction Act of 2019 from 116th Congress; Senate Finance Committee Prescription Drug Pricing Reform Principles; Implementation of American Rescue Plan Act of 2021 (PL 117-2) H.R. 5376, Build Back Better Act; Monitor Possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; Proposed repeal of the CMS Rule on Most Favored Nation Model; Delay of the Rebate Rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Copyright/Patent/Trademark CPT
S. 1435, Affordable Prescriptions for Patients Act of 2021
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.